Minerva Neurosciences
NERV
21 hedge funds and large institutions have $5.42M invested in Minerva Neurosciences in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
5% more funds holding
Funds holding: 20 → 21 (+1)
4.52% less ownership
Funds ownership: 34.56% → 30.04% (-4.5%)
64% less capital invested
Capital invested by funds: $14.9M → $5.42M (-$9.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$433K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$288K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$215K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$102K |
| 5 |
Morgan Stanley
New York
|
+$27.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.02M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$11.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$338 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$18 |
NERV Hedge Fund Activity: Q1 2024 in Review
21 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2024, worth a combined $5.42M — down 64% from $14.9M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NERV positions and 1 closed out — a net gain of 1 holder — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $433K. The largest seller was Fidelity Investments, exiting entirely with an estimated $3.02M sold.
- 21 institutional investors held Minerva Neurosciences (NERV) as of Q1 2024, up from 20 in Q4 2023.
- Funds reported $5.42M of Minerva Neurosciences stock for Q1 2024, down 64% quarter-over-quarter.
- 2 funds opened new Minerva Neurosciences positions in Q1 2024 and 1 closed out, a net change of +1 holder.
- The largest Minerva Neurosciences buyer in Q1 2024 was Renaissance Technologies, an estimated $433K added.
- The largest Minerva Neurosciences seller in Q1 2024 was Fidelity Investments, an estimated $3.02M sold.
Based on aggregated 13F filings for Q1 2024.